TY - JOUR
T1 - TP63 P2 promoter functional analysis identifies Β-catenin as a key regulator of Δnp63 expression
AU - Ruptier, C.
AU - De Gaspéris, A.
AU - Ansieau, S.
AU - Granjon, A.
AU - Tanière, P.
AU - Lafosse, I.
AU - Shi, H.
AU - Petitjean, A.
AU - Taranchon-Clermont, E.
AU - Tribollet, V.
AU - Voeltzel, T.
AU - Scoazec, J. Y.
AU - Maguer-Satta, V.
AU - Puisieux, A.
AU - Hainaut, P.
AU - Cavard, C.
AU - De Fromentel, C. Caron
N1 - Funding Information:
We thank Drs W Dinjens (University Medical Center, Rotterdam, The Netherlands) and A Costanzo (University of Rome, Italy) for the generous gift of TE-10 cells and pGL3-P2 plasmid, respectively; Drs J Zucmann-Rossi (INSERM U674, Paris, France) and B Terris (Institut Cochin, Paris, France) for the analysis of DNp63 expression in HCC samples; Dr B Abedi for her help for IHC experiments; Dr G Martel-Planche and A Masquelet and Ms A Durand and A Charnay for technical assistance; Drs S Sentis, G Hinkal and S and D Cox for critical reading of the manuscript. This project was supported by INSERM and the Association pour la Recherche contre le Cancer (grant number 3117). CR and HS were funded by the French Ligue Nationale Contre le Cancer, AP by the French Ministère de l’Enseignement et de la Recherche, and ET, PT, and VT by the International Agency for Research on Cancer.
PY - 2011/11/17
Y1 - 2011/11/17
N2 - The ΔNp63 protein, a product of the TP63 gene that lacks the N-terminal domain, has a critical role in the maintenance of self renewal and progenitor capacity in several types of epithelial tissues. ΔNp63 is frequently overexpressed in squamous cell carcinoma (SCC) and in some other epithelial tumours. This overexpression may contribute to tumour progression through dominant-negative effects on the transcriptionally active (TA) isoforms of the p53 family (TAp63, TAp73 and p53), as well as through independent mechanisms. However, the molecular basis of ΔNp63 overexpression is not fully understood. Here, we show that the expression of ΔNp63 is regulated by the Wnt/Β-catenin pathway in human hepatocellular carcinoma (HCC) and SCC cell lines. This regulation operates in particular through TCF/LEF sites present in the P2 promoter of TP63. In addition, we show that ΔNp63 and Β-catenin are frequently coexpressed and accumulated in oesophageal SCC, but not in HCC. These results suggest that activation of the Β-catenin pathway may contribute to overexpression of ΔNp63 during tumour progression, in a cell type-specific manner.
AB - The ΔNp63 protein, a product of the TP63 gene that lacks the N-terminal domain, has a critical role in the maintenance of self renewal and progenitor capacity in several types of epithelial tissues. ΔNp63 is frequently overexpressed in squamous cell carcinoma (SCC) and in some other epithelial tumours. This overexpression may contribute to tumour progression through dominant-negative effects on the transcriptionally active (TA) isoforms of the p53 family (TAp63, TAp73 and p53), as well as through independent mechanisms. However, the molecular basis of ΔNp63 overexpression is not fully understood. Here, we show that the expression of ΔNp63 is regulated by the Wnt/Β-catenin pathway in human hepatocellular carcinoma (HCC) and SCC cell lines. This regulation operates in particular through TCF/LEF sites present in the P2 promoter of TP63. In addition, we show that ΔNp63 and Β-catenin are frequently coexpressed and accumulated in oesophageal SCC, but not in HCC. These results suggest that activation of the Β-catenin pathway may contribute to overexpression of ΔNp63 during tumour progression, in a cell type-specific manner.
KW - p53 family
KW - promoter
KW - transcriptional regulation
KW - tumour progression
KW - β-catenin
UR - http://www.scopus.com/inward/record.url?scp=81255168184&partnerID=8YFLogxK
U2 - 10.1038/onc.2011.171
DO - 10.1038/onc.2011.171
M3 - Article
C2 - 21643019
AN - SCOPUS:81255168184
SN - 0950-9232
VL - 30
SP - 4656
EP - 4665
JO - Oncogene
JF - Oncogene
IS - 46
ER -